ATCC announces new award from BARDA to further support its medical countermeasures clinical studies network

ATCC, the world’s premier biological materials management and standards organization, today announced a Task Order award with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS).

As part of this award, ATCC, a member of BARDA’s Clinical Studies Network (CSN), operates the CSN’s Biological Specimen and Investigational Product (BSIP) storage facility and provides centralized services, storage, and distribution of its clinical samples and investigational products across BARDA-supported studies.

“Since 2020, ATCC has been a partner in BARDA’s Clinical Study Network using demonstrated best practices for the safe and secure management of biological specimens,”

Raymond H. Cypess, DVM, Ph.D., Chairman and CEO of ATC

Raymond added, “This award is another example of our ongoing support for medical countermeasures development to protect public health and safety.”

This task order is specific to storing biosafety level 3 (BSL-3) select agents and non-select agent materials for BARDA under the Biological Specimen and Investigational Product (BSIP) program. ATCC will coordinate all tasks for chain-of-custody monitoring and specimen handling, including collection, receipt, storage, inventory, retrieval, packaging, distribution, and disposition of these highly pathogenic agents and toxins, which can potentially pose a severe threat to the public or animal health.

“We look forward to continuing to build our relationship with BARDA through this task order,” 

Joseph Leonelli, Ph.D., Senior Vice President and General Manager of ATCC Federal Solutions

Joseph added, “As the premier biological materials and information resource and standards organization, we are committed to supporting critical government clinical studies aimed at developing medical countermeasures to improve the health and safety of our country.”

This project has been supported in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; BARDA, under Task Order Number 75A50123F33007 under Contract Number 75A50120D00013.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    American Type Culture Collection (ATCC). (2023, June 29). ATCC announces new award from BARDA to further support its medical countermeasures clinical studies network. News-Medical. Retrieved on June 16, 2024 from https://www.news-medical.net/news/20230629/ATCC-announces-new-award-from-BARDA-to-further-support-its-medical-countermeasures-clinical-studies-network.aspx.

  • MLA

    American Type Culture Collection (ATCC). "ATCC announces new award from BARDA to further support its medical countermeasures clinical studies network". News-Medical. 16 June 2024. <https://www.news-medical.net/news/20230629/ATCC-announces-new-award-from-BARDA-to-further-support-its-medical-countermeasures-clinical-studies-network.aspx>.

  • Chicago

    American Type Culture Collection (ATCC). "ATCC announces new award from BARDA to further support its medical countermeasures clinical studies network". News-Medical. https://www.news-medical.net/news/20230629/ATCC-announces-new-award-from-BARDA-to-further-support-its-medical-countermeasures-clinical-studies-network.aspx. (accessed June 16, 2024).

  • Harvard

    American Type Culture Collection (ATCC). 2023. ATCC announces new award from BARDA to further support its medical countermeasures clinical studies network. News-Medical, viewed 16 June 2024, https://www.news-medical.net/news/20230629/ATCC-announces-new-award-from-BARDA-to-further-support-its-medical-countermeasures-clinical-studies-network.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.